• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性间皮瘤与反应性间皮细胞的细胞学分型诊断及p16的荧光原位杂交分析

Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.

作者信息

Hiroshima Kenzo, Wu Di, Hasegawa Mizue, Koh Eitetsu, Sekine Yasuo, Ozaki Daisuke, Yusa Toshikazu, Walts Ann E, Marchevsky Alberto M, Nabeshima Kazuki, Tada Yuji, Shimada Hideaki, Tagawa Masatoshi

机构信息

Department of Pathology, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.

Department of Respirology, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.

出版信息

Diagn Cytopathol. 2016 Jul;44(7):591-8. doi: 10.1002/dc.23490. Epub 2016 Apr 15.

DOI:10.1002/dc.23490
PMID:27079839
Abstract

BACKGROUND

Mesothelioma patients often present with serosal effusions, which are ideal for cytopathological diagnoses. However, the morphological overlap between malignant and benign mesothelial proliferation can make a conclusive cytological diagnosis of mesothelioma elusive because immunohistochemical staining does not discriminate definitively between the two in this setting. p16 is deleted in up to 80% of pleural mesotheliomas. The aim of this study was to establish the correlation between the p16 deletion status of the cell block with that of its corresponding tumor using fluorescence in situ hybridization (FISH) analysis for individual patient tumors.

METHODS

Twenty-two biopsies and 24 corresponding cell blocks, containing serosal effusions with atypical mesothelial cells from 22 patients with histologically confirmed pleural mesotheliomas, were analyzed with p16 FISH. Seventeen cell blocks consisting of serosal effusions with reactive mesothelial cells from nonmesothelioma cases were also analyzed. Combined immunofluorescence and FISH were also performed.

RESULTS

Seventeen of the 22 mesothelioma patients (77.3%) showed homozygous deletions of p16 in the tumor tissue and in the atypical mesothelial cells from the cell blocks. p16 FISH followed by immunofluorescence with EMA was helpful towards identifying the mesothelioma cells in the cell blocks.

CONCLUSION

We confirmed that the p16 FISH results obtained from the cell blocks are as reliable as those from the tissue sections. Cell block analysis is recommended for patients with serosal effusions of unknown origins with the following methods: immunohistochemistry should be performed to validate the mesothelial origin, and p16 FISH should be performed to confirm malignancy. Diagn. Cytopathol. 2016;44:591-598. © 2016 Wiley Periodicals, Inc.

摘要

背景

间皮瘤患者常伴有浆膜腔积液,这是细胞病理学诊断的理想样本。然而,恶性和良性间皮细胞增生在形态学上存在重叠,这使得间皮瘤的确定性细胞学诊断难以实现,因为在这种情况下免疫组化染色无法明确区分两者。高达80%的胸膜间皮瘤存在p16基因缺失。本研究的目的是通过荧光原位杂交(FISH)分析个体患者肿瘤,确定细胞块中p16基因缺失状态与其相应肿瘤的p16基因缺失状态之间的相关性。

方法

对22例经组织学确诊的胸膜间皮瘤患者的22份活检标本和24份相应的细胞块进行p16 FISH分析,这些细胞块包含有非典型间皮细胞的浆膜腔积液。还对17份由非间皮瘤病例的反应性间皮细胞组成的浆膜腔积液细胞块进行了分析。同时进行了联合免疫荧光和FISH检测。

结果

22例间皮瘤患者中有17例(77.3%)在肿瘤组织和细胞块中的非典型间皮细胞中显示出p16基因纯合缺失。先进行p16 FISH,然后用EMA进行免疫荧光检测,有助于识别细胞块中的间皮瘤细胞。

结论

我们证实从细胞块获得的p16 FISH结果与从组织切片获得的结果一样可靠。对于来源不明的浆膜腔积液患者,建议采用以下方法进行细胞块分析:应进行免疫组化以验证间皮来源,应进行p16 FISH以确认恶性肿瘤。诊断细胞病理学。2016;44:591 - 598。©2016威利期刊公司。

相似文献

1
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.恶性间皮瘤与反应性间皮细胞的细胞学分型诊断及p16的荧光原位杂交分析
Diagn Cytopathol. 2016 Jul;44(7):591-8. doi: 10.1002/dc.23490. Epub 2016 Apr 15.
2
BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.BAP1免疫染色及CDKN2A(p16)荧光原位杂交分析:在胸腔积液中诊断恶性间皮瘤的临床应用
Diagn Cytopathol. 2016 Jul;44(7):599-606. doi: 10.1002/dc.23491. Epub 2016 Apr 28.
3
New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?区分良性与恶性间皮增生的新标志物:我们做到了吗?
Arch Pathol Lab Med. 2016 Apr;140(4):318-21. doi: 10.5858/arpa.2015-0240-SA. Epub 2015 Aug 19.
4
Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.使用p16荧光原位杂交技术对涂片标本中的间皮瘤进行鉴别诊断。
Diagn Cytopathol. 2016 Sep;44(9):774-80. doi: 10.1002/dc.23501. Epub 2016 May 24.
5
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.BAP1免疫组化和p16(CDKN2A)荧光原位杂交技术在胸腔积液细胞学标本恶性间皮瘤诊断中的应用价值
Am J Surg Pathol. 2016 Jan;40(1):120-6. doi: 10.1097/PAS.0000000000000529.
6
Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.胸腔积液细胞学中 BAP1 缺失和 p16(CDKN2A)缺失分析对间皮瘤明确诊断的贡献。
Eur Rev Med Pharmacol Sci. 2023 Oct;27(20):10001-10007. doi: 10.26355/eurrev_202310_34180.
7
[Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].[荧光原位杂交和免疫组织化学检测恶性间皮瘤中的p16]
Zhonghua Bing Li Xue Za Zhi. 2015 Apr;44(4):262-5.
8
The importance of FISH signal cut-off values for 9p21 deletion in malignant pleural mesothelioma: Is it underestimated?恶性胸膜间皮瘤中 9p21 缺失的 FISH 信号截断值的重要性:是否被低估了?
Pathol Res Pract. 2019 Jun;215(6):152377. doi: 10.1016/j.prp.2019.03.006. Epub 2019 Mar 4.
9
p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma.p16 FISH 缺失在表面上皮间皮增生中具有预测潜在侵袭性间皮瘤的作用。
Am J Surg Pathol. 2014 May;38(5):681-8. doi: 10.1097/PAS.0000000000000176.
10
Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.积液涂片标本中p16的缺失状态与潜在的恶性胸膜间皮瘤组织的缺失状态相关。
Cancer Sci. 2015 Nov;106(11):1635-41. doi: 10.1111/cas.12769. Epub 2015 Oct 15.

引用本文的文献

1
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).间皮瘤中的端粒与端粒酶:病理生理学、生物标志物及新兴治疗策略(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
2
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.临床肿瘤分子标志物检测技术指南 第 2 版 解读 2
Int J Clin Oncol. 2024 May;29(5):512-534. doi: 10.1007/s10147-024-02497-0. Epub 2024 Mar 17.
3
Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma.
恶性胸膜间皮瘤细胞学与分子诊断的综合方法
Transl Lung Cancer Res. 2020 Jun;9(3):934-943. doi: 10.21037/tlcr-2019-pps-10.
4
Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.区分恶性与良性间皮性胸膜增生的分子标志物和新诊断方法:文献综述
J Thorac Dis. 2018 Jan;10(Suppl 2):S342-S352. doi: 10.21037/jtd.2017.10.88.
5
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.生存素、BAP1和Ki-67免疫组化在鉴别上皮样间皮瘤与反应性间皮增生中的应用
Oncol Lett. 2018 Mar;15(3):3540-3547. doi: 10.3892/ol.2018.7765. Epub 2018 Jan 10.
6
A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.一例诊断困难的细胞性胸腔积液病例:形态学、免疫组织化学及荧光原位杂交研究
Cytojournal. 2017 Jul 24;14:18. doi: 10.4103/cytojournal.cytojournal_54_16. eCollection 2017.